Medicine and Dentistry

1. Patient 100%
2. Esophageal Adenocarcinoma 67%
3. Neoadjuvant Chemotherapy 53%
4. Surgical Margin 32%
5. Hazard Ratio 28%
6. Neoplasm 28%
7. Positron Emission Tomography-Computed Tomography 25%
8. Esophagectomy 25%
9. Chemotherapy 25%
10. Analysis 24%
11. Lymph Node 24%
12. Adenocarcinoma 22%
13. Cancer Surgery 20%
14. Upper Gastrointestinal Cancer 18%
15. Adjuvant Therapy 18%
16. Esophageal Cancer 15%
17. Recurrent Disease 15%
18. Stomach Adenocarcinoma 12%
19. Experience 11%
20. Therapeutic Procedure 11%
21. Follow up 9%
22. PET-MRI 9%
23. Esophagus 9%
24. Tomography 9%
25. Fluorodeoxyglucose 9%
26. Fluorodeoxyglucose F 18 9%
27. Endoscopic Ultrasound 9%
28. Surgical Anastomosis 9%
29. Ultrasound Computed Tomography 9%
30. Breast 9%
31. Symptom 9%
32. Proportional Hazards Model 8%
33. Adjuvant Chemoradiotherapy 6%
34. Primary Tumor 6%
35. Age 6%
36. Adjuvant Chemotherapy 5%
37. Mixed Tumor 5%